Search results for: 'learning ad developement'

02 Jun 2021  |  North America  |  Market Research

Global Benchmarking of Select Cities and their Data and Digital Strategies, 2021

Cities with a Well-structured Digital Strategy will be able to Dramatically Enhance Livability

Infographics

×

Digitization is the bedrock of new technology and services expansion, new mobility solutions, and smart applications in city management. Its purview extends across a city’s digital performance and digital strategy. In terms of digital performance, this measures how a city fares in terms of smartphone penetration, 4G coverage and speed, its 5G outlo...

Indonesia is a prominent data center colocation services market in Southeast Asia. With increasing implementation of digital transformation initiatives, favorable government policies toward digital technology adoption, and improvements in the countrys connectivity and network infrastructure, the market is expected to continue growing. Enterprises a...

29 Oct 2021  |  Global  |  Frost Radar

Frost Radar™: Greater China Web Application Firewall Solutions Market, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The COVID 19 pandemic has triggered the acceleration of digital transformation. Organizations are rapidly expanding their digital capacity to survive and thrive in the fast-changing business environment. To cope with the disruptions brought by the pandemic, organizations today heavily rely on web and mobile applications to connect with customers, b...

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

This study provides an overview of the space force capacity structure of the Asia-Pacific. With an increase in tensions and conflict zones across the globe, military space capabilities have expanded to anticipate threats, respond to crises, and project power, guiding the development of offensive and defensive strategies vital to national interests....

Our society's approach to producing, consuming, and distributing energy is changing due to mounting concerns about global warming and rising CO2 levels in the atmosphere. Governments worldwide are formulating regulatory frameworks, increasing their investments in low-carbon technologies to slow climate change, and decarbonizing their economies. An ...

Sustainability targets in businesses are increasing to mitigate the risk of stringent regulations, taxation, and, more importantly, to meet customer demand for more environmentally friendly products. To achieve these goals, businesses adopt decarbonization strategies and invest in low-carbon technologies and services at different stages of the supp...

Changing regulatory landscapes significantly impact the chemical industry s evolution in technological advancement, product development, vertical integration, and consolidation activities. In a recent Frost & Sullivan report titled The Impact of Regulations on the Chemical Industry (PE52), we found that one of the key areas of regulation is in P...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...